APA Citatie

Svaton, M., Fiala, O., Krakorova, G., Blazek, J., Hurdalkova, K., Barinova, M., . . . Pesek, M. (2020). Thyroid transcription factor 1 and p63 expression is associated with survival outcome in patients with non-small cell lung cancer treated with erlotinib. Oncol Lett.

Chicago Style citaat

Svaton, Martin, Ondrej Fiala, Gabriela Krakorova, Jiri Blazek, Karolina Hurdalkova, Magda Barinova, Petr Mukensnabl, en Milos Pesek. "Thyroid Transcription Factor 1 and P63 Expression Is Associated With Survival Outcome in Patients With Non-small Cell Lung Cancer Treated With Erlotinib." Oncol Lett 2020.

MLA citatie

Svaton, Martin, et al. "Thyroid Transcription Factor 1 and P63 Expression Is Associated With Survival Outcome in Patients With Non-small Cell Lung Cancer Treated With Erlotinib." Oncol Lett 2020.